Overview
Genhua Mu practices practicing medicine in Yancheng, China.
Their clinical expertise encompasses Chronic Familial Neutropenia, Sepsis, Acute Respiratory Distress Syndrome (ARDS), and Severe Acute Respiratory Syndrome (SARS).
They are actively involved in clinical research, co-authoring 12 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Genhua Mu
Is Genhua Mu a top-rated expert for Chronic Familial Neutropenia?
MediFind is an objective health platform that identifies experts based on real-world data. Genhua Mu is classified as an Experienced expert for Chronic Familial Neutropenia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Genhua Mu participate in research or clinical trials?
Yes. Genhua Mu has published 12 articles and abstracts on conditions like Chronic Familial Neutropenia. You can view a list of Genhua Mu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- Chronic Familial Neutropenia
- COVID-19Mu isExperienced. Learn about COVID-19.
- SepsisMu isExperienced. Learn about Sepsis.
- Severe Acute Respiratory Syndrome (SARS)